Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,602,287
-
Share change
-
-6,641,290
-
Total reported value
-
$42,385,329
-
Put/Call ratio
-
58%
-
Price per share
-
$1.19
-
Number of holders
-
88
-
Value change
-
-$8,922,478
-
Number of buys
-
33
-
Number of sells
-
56
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q3 2022
As of 30 Sep 2022,
CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,602,287 shares.
The largest 10 holders included
VANGUARD GROUP INC, Palo Alto Investors LP, BlackRock Inc., QVT Financial LP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, PINNACLE ASSOCIATES LTD, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
88
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.